Preinvasive adenocarcinoma lesion of the lung

Changed by Brian Gilcrease-Garcia, 30 Oct 2018

Updates to Article Attributes

Body was changed:

Preinvasive lesions for lung adenocarcinoma are a category of small noninvasivenon-invasive lung lesions which are closely related to adenocarcinoma of the lung. They may represent a spectrum of premalignant to low-grade malignant lesions.

The category includes two types of lesions:

Terminology

In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.

Pathology

Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where :

  • atypical adenomatous hyperplasia is typically a small (≤5 mm) lesion with mild-moderate cellular atypia, while
  • adenocarcinoma in situ lesions are larger, yet still ≤3 cm and demonstrating purely lepidic growth (no invasion). Indeed

Between these two, intermediate cases may be difficult to distinguish 1.

Findings which indicate more profound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicatemoreindicate a more advanced grade of disease.

Radiographic features

Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.

On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a round, purely ground glass opacity.

  • usually a single opacity 2
    • multiple lesions more common with AIS 2
  • "clear" periphery (>85%) 2
    • lobuation, spiculation, pleural indentation are seen in both AAH and AIS, but less common (<21%)
  • vacuole sign - internal gas-appearing lucency <5 mm
    • specific to AIS in one 2017 radiology/pathology correlative study (n=80 lesions) 2
  • -<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a category of small noninvasive lung lesions which are closely related to <a href="/articles/adenocarcinoma-of-the-lung">adenocarcinoma of the lung</a>. They may represent a spectrum of premalignant to low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>
  • +<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a category of small non-invasive lung lesions which are closely related to <a href="/articles/adenocarcinoma-of-the-lung">adenocarcinoma of the lung</a>. They may represent a spectrum of premalignant to low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>
  • -</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (≤5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, yet still ≤3 cm and demonstrating purely lepidic growth (no invasion). Indeed, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more profound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicatemore advanced grade of disease.</p><h4>Radiographic features</h4><p>Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.</p><p>On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a round, purely ground glass opacity.</p><ul>
  • +</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease:</p><ul>
  • +<li>atypical adenomatous hyperplasia is typically a small (≤5 mm) lesion with mild-moderate cellular atypia</li>
  • +<li>adenocarcinoma in situ lesions are larger, yet still ≤3 cm and demonstrating purely lepidic growth (no invasion)</li>
  • +</ul><p>Between these two, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more profound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicate a more advanced grade of disease.</p><h4>Radiographic features</h4><p>Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.</p><p>On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a round, purely ground glass opacity.</p><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.